Cargando…
Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia
Expression of ζ-chain-associated protein kinase 70 kDa (ZAP-70) in chronic lymphocytic leukemia (CLL) is associated with more aggressive disease and can help differentiate CLL from cases expressing mutated or unmutated immunoglobulin heavy chain variable region (IgHV) genes. However, standardizing Z...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762435/ https://www.ncbi.nlm.nih.gov/pubmed/26937202 http://dx.doi.org/10.2147/OTT.S94613 |
_version_ | 1782417111933517824 |
---|---|
author | Wu, Yu-Jie Wang, Hui Liang, Jian-Hua Miao, Yi Liu, Lu Qiu, Hai-Rong Qiao, Chun Wang, Rong Li, Jian-Yong |
author_facet | Wu, Yu-Jie Wang, Hui Liang, Jian-Hua Miao, Yi Liu, Lu Qiu, Hai-Rong Qiao, Chun Wang, Rong Li, Jian-Yong |
author_sort | Wu, Yu-Jie |
collection | PubMed |
description | Expression of ζ-chain-associated protein kinase 70 kDa (ZAP-70) in chronic lymphocytic leukemia (CLL) is associated with more aggressive disease and can help differentiate CLL from cases expressing mutated or unmutated immunoglobulin heavy chain variable region (IgHV) genes. However, standardizing ZAP-70 expression by flow cytometric analysis has proved unsatisfactory. The key point is that ZAP-70 is weakly expressed with a continuous expression pattern rather than a clear discrimination between positive and negative CLL cells, which means that the resulting judgment is subjective. Thus, in this study, we aimed at assessing the reliability and repeatability of ZAP-70 expression using the geometric mean fluorescence intensity (geo MFI) index method based on flow cytometry with 256-channel resolution in a series of 402 CLL patients and to compare ZAP-70 with other biological and clinical prognosticators. According to IgHV mutational status, we were able to confirm that the optimal cut-off point for the geo MFI index was 3.5 in the test set. In multivariate analyses that included the major clinical and biological prognostic markers for CLL, the prognostic impact of ZAP-70 expression appeared to have stronger discriminatory power when the geo MFI index method was applied. In addition, we found that ZAP-70-positive patients according to the geo MFI index method had shorter time to first treatment or overall survival (P=0.0002, P=0.0491). This is the first report showing that ZAP-70 expression can be evaluated by a new approach, the geo MFI index, which could be a useful prognostic method as it is more reliable, less subjective, and therefore better associated with improvement of CLL prognostication and prediction of clinical course. |
format | Online Article Text |
id | pubmed-4762435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-47624352016-03-02 Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia Wu, Yu-Jie Wang, Hui Liang, Jian-Hua Miao, Yi Liu, Lu Qiu, Hai-Rong Qiao, Chun Wang, Rong Li, Jian-Yong Onco Targets Ther Original Research Expression of ζ-chain-associated protein kinase 70 kDa (ZAP-70) in chronic lymphocytic leukemia (CLL) is associated with more aggressive disease and can help differentiate CLL from cases expressing mutated or unmutated immunoglobulin heavy chain variable region (IgHV) genes. However, standardizing ZAP-70 expression by flow cytometric analysis has proved unsatisfactory. The key point is that ZAP-70 is weakly expressed with a continuous expression pattern rather than a clear discrimination between positive and negative CLL cells, which means that the resulting judgment is subjective. Thus, in this study, we aimed at assessing the reliability and repeatability of ZAP-70 expression using the geometric mean fluorescence intensity (geo MFI) index method based on flow cytometry with 256-channel resolution in a series of 402 CLL patients and to compare ZAP-70 with other biological and clinical prognosticators. According to IgHV mutational status, we were able to confirm that the optimal cut-off point for the geo MFI index was 3.5 in the test set. In multivariate analyses that included the major clinical and biological prognostic markers for CLL, the prognostic impact of ZAP-70 expression appeared to have stronger discriminatory power when the geo MFI index method was applied. In addition, we found that ZAP-70-positive patients according to the geo MFI index method had shorter time to first treatment or overall survival (P=0.0002, P=0.0491). This is the first report showing that ZAP-70 expression can be evaluated by a new approach, the geo MFI index, which could be a useful prognostic method as it is more reliable, less subjective, and therefore better associated with improvement of CLL prognostication and prediction of clinical course. Dove Medical Press 2016-02-18 /pmc/articles/PMC4762435/ /pubmed/26937202 http://dx.doi.org/10.2147/OTT.S94613 Text en © 2016 Wu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Wu, Yu-Jie Wang, Hui Liang, Jian-Hua Miao, Yi Liu, Lu Qiu, Hai-Rong Qiao, Chun Wang, Rong Li, Jian-Yong Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia |
title | Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia |
title_full | Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia |
title_fullStr | Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia |
title_full_unstemmed | Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia |
title_short | Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia |
title_sort | using the geometric mean fluorescence intensity index method to measure zap-70 expression in patients with chronic lymphocytic leukemia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762435/ https://www.ncbi.nlm.nih.gov/pubmed/26937202 http://dx.doi.org/10.2147/OTT.S94613 |
work_keys_str_mv | AT wuyujie usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT wanghui usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT liangjianhua usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT miaoyi usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT liulu usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT qiuhairong usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT qiaochun usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT wangrong usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia AT lijianyong usingthegeometricmeanfluorescenceintensityindexmethodtomeasurezap70expressioninpatientswithchroniclymphocyticleukemia |